Improving Advance Care Planning by Care Partners of Persons Living With Dementia Using a Narrative Video Game (ANTICIPATE)
The primary objective of this study is to evaluate the feasibility of using a narrative video game intervention to improve advance care planning (ACP) among care partners of people living with Alzheimer's Disease and Related Dementia. Feasibility will be assessed by evaluating acceptability as well as the fidelity of intervention delivery.
調査の概要
詳細な説明
The trial is designed to establish the feasibility and plausibility of using the intervention to alter psychological outcomes, necessary to justify a future Type 1 hybrid effectiveness-implementation trial.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Deepika Mohan, MD, MPH
- 電話番号:412-647-0835
- メール:mohand@upmc.edu
研究連絡先のバックアップ
- 名前:Caroline J Pidro
- 電話番号:412-383-0821
- メール:cjl13@pitt.edu
研究場所
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、アメリカ、15213
- University of Pittsburgh
-
コンタクト:
- Deepika Mohan, MD, MPH
- 電話番号:412-647-0835
- メール:mohand@upmc.edu
-
コンタクト:
- Caroline J Pidro
- 電話番号:412-383-0821
- メール:cjl13@pitt.edu
-
主任研究者:
- Deepika Mohan, MD, MPH
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Be 18 years or older
- Identify as the primary support person (care partner) for health-related decisions for a person with dementia
Exclusion Criteria:
- the person with dementia has died
- the care partner does not have an email address
- the care partner is unwilling to be recorded
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:他の
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Pre and Post Intervention (Narrative Video Game) Assessment
Participants in this arm will complete the Surrogate ACP Readiness Survey prior to intervention exposure. Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
他の名前:
|
|
実験的:Post-Intervention (Narrative Video Game) Assessment Only
Participants will schedule a video-conference visit with the research facilitator. During the session, they will be asked to use the intervention (ANTICIPATE), a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The experience takes 20-30 minutes to complete. Immediately following intervention exposure, participants will be asked to complete the User Engagement Survey, the Acceptability, Appropriateness, and Feasibility Measures, and the Surrogate ACP Readiness Survey. |
The intervention (ANTICIPATE) is a narrative video game that asks users to rehearse making an end-of-life medical decision for a fictional character. The game begins with an introduction to the main character (Glenn), then proceeds to demonstrating loss of function secondary to progression of dementia, then describes Glenn as experiencing a serious illness and requiring intubation or palliation. The player, who has taken on the role of Glenn's daughter, must consider her father's preferences and functional status as she decides how to proceed.
他の名前:
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Acceptability of the intervention (co-primary)
時間枠:Immediately following intervention exposure
|
Proportion of participants who score the intervention as ≥4/5 on the Acceptability of Intervention Measure |
Immediately following intervention exposure
|
|
Fidelity of intervention delivery (co-primary)
時間枠:3 months post-intervention exposure
|
Proportion of participants who complete all study tasks |
3 months post-intervention exposure
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Fidelity of intervention receipt
時間枠:Pre-intervention to 3 months post-intervention
|
Mean responses to the items on the ACP Engagement Survey for Surrogate Decision makers and then summarized by domain (knowledge, readiness, self-efficacy, contemplation). |
Pre-intervention to 3 months post-intervention
|
|
Fidelity of intervention enactment (self-reported completion of ACP)
時間枠:3 months post-intervention
|
Proportion of participants who report ACP activities after intervention exposure |
3 months post-intervention
|
|
Fidelity of behavior change technique delivery
時間枠:Immediately post-intervention
|
Proportion of participants who report the use of behavioral rehearsal during the game or who demonstrate the use of rehearsal during game play. |
Immediately post-intervention
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Amber Barnato, MD, MPH, MS、Dartmouth College
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- STUDY26060072
- R21AG098846 (米国 NIH グラント/契約)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
All collected and de-identified individual participant data.
IPD 共有時間枠
It will be made available within 6 months of completion of the study, and will be available for 7 years.
IPD 共有アクセス基準
We will upload the data to a data repository (ICPSR), and researchers may access it by following the protocols set by the repository.
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
- CSR
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。